The study attempts to conduct randomized double-blind controlled trials to understand whether daily exposure to microplastics (MPs) can cause potential impacts on human health, explore whether the intake of Lactiplantibacillus plantarum PD01 can alleviate potential obesity-related damages caused by MPs, and provide a scientific basis for the prevention and nutritional intervention of health hazards caused by MP exposure.
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Fecal microplastics (MPs) levels as assessed by Py-GC/MS
Timeframe: Up to 2 months
Gut microbiota composition as assessed by Fecal Metagenomics
Timeframe: Up to 2 months
Blood metabolic profiles as assessed by Blood Metabolomics
Timeframe: Up to 2 months
Inflammatory cytokines and immune markers
Timeframe: Up to 2 months
Blood biochemical indicators as assessed by the Mindray BS200 automatic biochemical analyzer
Timeframe: Up to 2 months
Routine blood examination (Five-part differential)
Timeframe: Up to 2 months
Anthropometric and body composition indicators
Timeframe: Up to 2 months